Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prasugrel use and clinical outcomes by age among patients undergoing PCI for acute coronary syndrome: from the PROMETHEUS study

Published:2020-01-08 Issue:6 Volume:109 Page:725-734
ISSN:1861-0684
Container-title:Clinical Research in Cardiology
language:en
Short-container-title:Clin Res Cardiol

Author:

Chandrasekhar Jaya,Baber Usman,Sartori Samantha,Aquino Melissa,Moalem Kamilia,Kini Annapoorna S.,Rao Sunil V.,Weintraub William,Henry Timothy D.,Vogel Birgit,Ge Zhen,Muhlestein Joseph B.,Weiss Sandra,Strauss Craig,Toma Catalin,DeFranco Anthony,Claessen Bimmer E.,Keller Stuart,Baker Brian A.,Effron Mark B.,Pocock Stuart,Dangas George,Kapadia Samir,Mehran Roxana

Funder

Eli Lilly and Company

Daiichi-Sankyo

Publisher

Springer Science and Business Media LLC

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00392-019-01561-4.pdf

Reference25 articles.

1. Wang TY, Gutierrez A, Peterson ED (2011) Percutaneous coronary intervention in the elderly. Nat Rev Cardiol 8:79–90

2. Wimmer NJ, Resnic FS, Mauri L et al (2013) Risk-treatment paradox in the selection of transradial access for percutaneous coronary intervention. J Am Heart Assoc 2:e000174

3. Motivala AA, Cannon CP, Srinivas VS et al (2011) Changes in myocardial infarction guideline adherence as a function of patient risk: an end to paradoxical care? J Am Coll Cardiol 58:1760–1765

4. Ko DT, Mamdani M, Alter DA (2004) Lipid-lowering therapy with statins in high-risk elderly patients: the treatment-risk paradox. JAMA 291:1864–1870

5. Levine GN, Bates ER, Bittl JA et al (2016) 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Thorac Cardiovasc Surg 152:1243–1275

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of elderly patients with non-ST-elevation myocardial infarction: the nationwide POPular age registry;Netherlands Heart Journal;2023-09-28

2. Clopidogrel versus ticagrelor in East Asian patients aged 75 years or older with acute coronary syndrome: observations from the GF-APT registry;Platelets;2022-09-01

3. Ticagrelor vs. Clopidogrel in Older Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Insights From a Real-World Registry;Frontiers in Cardiovascular Medicine;2022-03-15

4. Comparison of One-Year Outcomes in Patients >75 Versus ≤75 Years With Coronary Artery Disease Treated With COMBO Stents (From The MASCOT Registry);The American Journal of Cardiology;2020-07

5. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial;The Lancet;2020-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3